Clinical Study
Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
Table 6
Efficacy of Goshajinkigan for treatment of peripheral neuropathy with respect to duration of Goshajinkigan administration.
| | GJG ≤ 3 weeks N = 8 | GJG ≥ 4 weeks N = 29 |
| Effect on peripheral neuropathy | Curative 0/8, 0% | Curative 1/29, 3.4% | Effective 1/8, 12.5% | Effective 6/29, 20.7% | Stabilizing 5/8, 62.5% | Stabilizing 20/29, 69.0% | Deleterious 2/8, 25.0% | Deleterious 2/29, 6.9% |
|
|